本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tarsus Pharmaceuticals, Inc.

70.82
-3.5800-4.81%
盘后:68.91-1.9142-2.70%19:30 EDT
成交量:163.28万
成交额:1.17亿
市值:31.08亿
市盈率:-65.43
高:75.02
开:74.50
低:70.32
收:74.40
52周最高:91.53
52周最低:53.89
股本:4,388.30万
流通股本:3,563.83万
量比:2.29
换手率:4.58%
股息:- -
股息率:- -
每股收益(TTM):-1.0824
每股收益(LYR):-1.5900
净资产收益率:-13.68%
总资产收益率:-5.48%
市净率:8.96
市盈率(LYR):-44.54

数据加载中...

2022/05/03

重要事件披露

8-K - Current report
2022/05/03

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/05/02

重要事件披露

8-K - Current report
2022/05/02

重要事件披露

8-K - Current report
2022/03/14

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/14

重要事件披露

8-K - Current report
2022/03/14

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/02

重要事件披露

8-K - Current report
2022/01/28

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/04

重要事件披露

8-K - Current report
2021/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/09

重要事件披露

8-K - Current report
2021/11/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/01

重要事件披露

8-K - Current report